Anticoagulants and fibrinolytic drugs

被引:0
|
作者
Sneader, W [1 ]
机构
[1] UNIV STRATHCLYDE, GLASGOW G1 1XQ, LANARK, SCOTLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:494 / 500
页数:7
相关论文
共 50 条
  • [31] Thrombin activatable fibrinolytic inhibitor (TAFI) is upregulated in patient populations: Effects of anticoagulants
    Florian-Kujawski, M
    Hoppensteadt, D
    Kereiakes, D
    Lewis, B
    Fareed, J
    LABORATORY INVESTIGATION, 2003, 83 (01) : 53A - 53A
  • [32] Natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis
    Al Ghumlas, Abeer Khalid
    Gader, Abdel Galil Mohammed Abdel
    Al Faleh, Faleh Zaid
    BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (04) : 263 - 267
  • [33] Thrombin activatable fibrinolytic inhibitor (TAFI) is upregulated in patient populations: Effects of anticoagulants
    Florian-Kujawski, M
    Hoppensteadt, D
    Kereiakes, D
    Lewis, B
    Fareed, J
    MODERN PATHOLOGY, 2003, 16 (01) : 53A - 53A
  • [34] New antiplatelet drugs and new oral anticoagulants
    Koenig-Oberhuber, V.
    Filipovic, M.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 : 74 - 84
  • [35] Hypersensitivity Reactions to modern Antiplatelet Drugs and Anticoagulants
    Hofmeier, Kathrin Scherer
    Bircher, Andreas J.
    ALLERGO JOURNAL, 2015, 24 (02) : 32 - 40
  • [36] INTERACTIONS OF ORAL COUMARIN ANTICOAGULANTS WITH OTHER DRUGS
    SANDLER, AI
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1970, 4 (06): : 146 - &
  • [37] Conundrums in the combined use of anticoagulants and antiplatelet drugs
    Schneider, David J.
    Sobel, Burton E.
    CIRCULATION, 2007, 116 (03) : 305 - 315
  • [38] ASPECTS OF MULTIPLE BINDING OF ANTICOAGULANTS AND OTHER DRUGS
    WOSILAIT, WD
    GENERAL PHARMACOLOGY, 1977, 8 (01): : 7 - 12
  • [39] Anticoagulants and antiplatelet drugs during cataract surgery
    Kara-Junior, Newton
    Koch, Camila Ribeiro
    de Santhiago, Marcony Rodrigues
    Fornari, Luciana
    Caramelli, Bruno
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2018, 81 (04) : 348 - 353
  • [40] Thrombolytic (fibrinolytic) drugs and progress in treating cardiovascular disease
    不详
    FASEB JOURNAL, 2005, 19 (06): : 671 - 671